CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 82 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,000 | -97.1% | 203 | -98.3% | 0.00% | – |
Q1 2021 | $34,000 | -91.7% | 12,070 | -91.0% | 0.00% | – |
Q4 2020 | $409,000 | -52.6% | 133,709 | -5.8% | 0.00% | -100.0% |
Q3 2020 | $863,000 | +2.9% | 142,009 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $839,000 | +159.0% | 142,009 | +16.0% | 0.00% | – |
Q1 2020 | $324,000 | -18.4% | 122,409 | -16.0% | 0.00% | – |
Q4 2019 | $397,000 | -77.5% | 145,809 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $1,767,000 | +5.8% | 145,809 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,670,000 | – | 145,809 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 325,000 | $861,000 | 4.66% |
MFN Partners Management, LP | 2,427,677 | $6,433,000 | 0.85% |
EcoR1 Capital, LLC | 2,742,276 | $7,267,000 | 0.76% |
Slate Path Capital LP | 1,196,063 | $3,170,000 | 0.24% |
Eversept Partners, LP | 337,145 | $893,434 | 0.22% |
Artal Group S.A. | 1,861,584 | $4,933,000 | 0.21% |
Alambic Investment Management, L.P. | 21,265 | $56,000 | 0.14% |
TRUSTCORE FINANCIAL SERVICES, LLC | 198,106 | $525,000 | 0.12% |
SPHERA FUNDS MANAGEMENT LTD. | 124,976 | $331,000 | 0.04% |
Broderick Brian C | 32,175 | $86,000 | 0.03% |